FGFR1 and breast cancer: NVP-BGJ398 (BGJ398) is an FGFR1/FGFR2/FGFR3 inhibitor that has exhibited anti-cancer effects in breast cancer cell lines, animal models, and Phase I/II clinical trials27, 28.